Clinical methods for the detection and management of left ventricular hypertrophy

Area of Science:

• Cardiology
• Cardiovascular Medicine
• Clinical Risk Assessment

Background:

• Left ventricular hypertrophy (LVH) is an established independent risk factor for adverse cardiac and cerebrovascular events.
• Current clinical practice lacks standardized methods for quantifying LVH and monitoring its regression.
• This deficiency hinders the effective clinical targeting of LVH as a primary risk factor.

Purpose of the Study:

• To provide a comprehensive review of current knowledge on LVH.
• To present standardized methods for accurate LVH detection.
• To outline management strategies for LVH regression, establishing it as a clinical therapeutic target.

Main Methods:

• Literature review of state-of-the-art research on LVH.
• Analysis of current diagnostic techniques for LVH quantification.
• Evaluation of existing and emerging therapeutic strategies for LVH management.

Main Results:

• LVH is a critical predictor of cardiovascular and cerebrovascular morbidity and mortality.
• Significant variability exists in current LVH assessment methods.
• Evidence supports the potential for therapeutic interventions to induce LVH regression.

Conclusions:

• Standardized LVH detection and monitoring are crucial for clinical application.
• Targeting LVH regression offers a promising therapeutic avenue for reducing adverse cardiac events.
• Further research and consensus are needed to implement standardized clinical protocols for LVH management.